About This Product
Optimum Nutrition Opti-Men is a multivitamin and multimineral supplement. Each 3-tablet serving provides a comprehensive blend of vitamins and essential minerals.
Strengths
- +Key ingredients at clinically effective doses
- +Fully transparent label with individual ingredient amounts disclosed
- +Broad ingredient diversity exceeding category norms
- +19 ingredient(s) at clinical dose levels
- +Rich formula with 38 active ingredients
Weaknesses
- −Missing several expected ingredients for its category
Ingredient Analysis (38 ingredients)
| Ingredient | Amount | Status |
|---|---|---|
| Vitamin K | 75.000 mcg | Adequate |
| Thiamine | 75.000 mg | Optimal |
| Riboflavin | 75.000 mg | Optimal |
| Niacin | 75.000 mg | N/A |
| Vitamin B6 | 50.000 mg | Optimal |
| Folate | 1020.000 mcg DFE | N/A |
| Vitamin B12 | 100.000 mcg | Optimal |
| Biotin | 300.000 mcg | Optimal |
| Pantothenic Acid | 75.000 mg | Optimal |
| Choline | 10.000 mg | Under |
| Vitamin A | 3000.000 mcg | Optimal |
| Vitamin C | 300.000 mg | Optimal |
| Vitamin D | 37.500 mcg | Under |
| Vitamin E | 134.000 mg | Optimal |
| Calcium | 50.000 mg | Under |
| Iodine | 150.000 mcg | Optimal |
| Magnesium | 80.000 mg | Under |
| Zinc | 15.000 mg | Optimal |
| Selenium | 200.000 mcg | Optimal |
| Copper | 2.000 mg | Optimal |
| Manganese | 2.000 mg | Optimal |
| Chromium | 120.000 mcg | Optimal |
| Boron | 2.000 mg | N/A |
| Sodium | 10.000 mg | N/A |
| Alpha-Lipoic Acid | 25.000 mg | N/A |
| Lycopene | 500.000 mcg | N/A |
| Molybdenum | 80.000 mcg | Optimal |
| Zeaxanthin | 28.000 mcg | N/A |
| Inositol | 10.000 mg | N/A |
| Lutein | 500.000 mcg | N/A |
| Vanadium | 100.000 mcg | N/A |
| PABA | 10.000 mg | N/A |
| Enzyme Blend | 50.000 mg | N/A |
| Alpha-Carotene | 140.000 mcg | N/A |
| Amino Men Blend | 1.000 Gram(s) | N/A |
| Phyto Men Blend | 100.000 mg | N/A |
| Viri Men Blend | 50.000 mg | N/A |
| Cryptoxanthin | 34.000 mcg | N/A |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.